{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihmhrdthg64t55ye3v3yxzjchojpxevnz7qjepiif72egbehwhlha",
    "uri": "at://did:plc:sgbcix3wjir5gnkm6ybi24kf/app.bsky.feed.post/3mkujtk3dr5k2"
  },
  "path": "/2026/05/01/repub/us-supreme-court-weighs-case-that-could-hinder-cheaper-drug-manufacturing/",
  "publishedAt": "2026-05-01T16:58:43.000Z",
  "site": "https://floridaphoenix.com",
  "tags": [
    "DC Bureau",
    "Health",
    "Politics & Law",
    "Working & The Economy",
    "Amarin Pharma Inc.",
    "Association for Accessible Medicines",
    "Brett Kavanaugh",
    "Charles Duan",
    "Charles Klein",
    "Hikma Pharmaceuticals USA Inc.",
    "John Bailey",
    "John Murphy",
    "Ketanji Brown Jackson",
    "Michael Huston",
    "skinny labels",
    "Tegan Berry",
    "U.S. Supreme Court"
  ],
  "textContent": "By Zara Norman/Medill News Service WASHINGTON — John Bailey said he’s saved tens of thousands of dollars over the last decade by relying on a generic prescription to lower his cholesterol. The 68-year-old from central Texas was able to get a generic because the patent on a brand-name medication expired. He and many other Americans […]",
  "title": "US Supreme Court weighs case that could hinder cheaper drug manufacturing"
}